Insulin sensitivity and body composition in cirrhosis: Changes after TIPS

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 2, 2010, Pages

  Holland Fischer, Peter ^a   Nielsen, Michael Festersen ^a   Vilstrup, Hendrik ^a   Tønner Nielsen, Dennis ^a   Mengel, Anette ^a   Schmitz, Ole ^a,b   Grønbæk, Henning ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Endogenous glucose production; Hyperinsulinemic euglycemic clamp; Metabolism; Oral glucose tolerance test; Resting energy expenditure

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; TRACER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; IMPEDANCE; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIVER CIRRHOSIS; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

BODY COMPOSITION; C-PEPTIDE; DIABETES MELLITUS; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PREDICTIVE VALUE OF TESTS; REST;

EID: 77955605669     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00375.2009     Document Type: Article

References (53)

1. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89-94, 2007. (Pubitemid 46052504)
2. Alberino F, Gatta A, Amodio P, Merkel C, Di PL, Boffo G, Caregaro L. Nutrition and survival in patients with liver cirrhosis. Nutrition 17: 445-450, 2001. (Pubitemid 32505665)
3. Albillos A, Banares R, Gonzalez M, Catalina MV, Molinero LM. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol 43: 990-996, 2005. (Pubitemid 41627984)
4. Allard JP, Chau J, Sandokji K, Blendis LM, Wong F. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol 96: 2442-2447, 2001. (Pubitemid 32769209)
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 28: S37-S42, 2005.
6. [Anon]. Nutritional status in cirrhosis. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. J Hepatol 21: 317-325, 1994.
7. Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, Radermacher P, Calzia E. Glucose metabolism and catecholamines. Crit Care Med 35: S508-S518, 2007.
8. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 19: 515-521, 2003. (Pubitemid 36627435)
9. Caregaro L, Alberino F, Amodio P, Merkel C, Bolognesi M, Angeli P, Gatta A. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr 63: 602-609, 1996.
10. Carstensen E, Yudkin JS. Platelet catecholamine concentrations after short-term stress in normal subjects. Clin Sci (Lond) 86: 35-41, 1994. (Pubitemid 24034705)
11. Cavallo-Perin P, Cassader M, Bozzo C, Bruno A, Nuccio P, Dall'omo AM, Marucci M, Pagano G. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest 75: 1659-1665, 1985.
12. DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38: 387-395, 1989. (Pubitemid 19105727)
13. Deschenes M, Somberg KA. Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus. Am J Gastroenterol 93: 483, 1998. (Pubitemid 29068368)
14. Edgerton DS, Lautz M, Scott M, Everett CA, Stettler KM, Neal DW, Chu CA, Cherrington AD. Insulin's direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest 116: 521-527, 2006.
15. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 37: 287-301, 1988. (Pubitemid 18080935)
16. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634, 1983.
17. Holland-Fischer P, Vilstrup H, Frystyk J, Nielsen DT, Flyvbjerg A, Gronbaek H. The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis. Eur J Endocrinol 160: 957-963, 2009.
18. Kalaitzakis E, Bosaeus I, Ohman L, Bjornsson E. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr 85: 808-815, 2007. (Pubitemid 46393514)
19. Kaser S, Foger B, Waldenberger P, Nachbaur K, Propst A, Jaschke W, Vogel W, Patsch JR. Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis. J Hepatol 33: 902-906, 2000.
20. Kasperska-Czyzykowa T, Heding LG, Czyzyk A. Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis. Diabetologia 25: 506-509, 1983. (Pubitemid 14200888)
21. Khan S, Tudur SC, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev CD000553, 2006.
22. Kondrup J, Muller MJ. Energy and protein requirements of patients with chronic liver disease. J Hepatol 27: 239-247, 1997. (Pubitemid 27357083)
23. Kruszynska Y, Williams N, Perry M, Home P. The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis. Hepatology 8: 1615-1619, 1988. (Pubitemid 19021897)
24. Kushner RF, Schoeller DA. Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr 44: 417-424, 1986. (Pubitemid 16052634)
25. Lafortune M, Martinet JP, Denys A, Patriquin H, Dauzat M, Dufresne MP, Colombato L, Pomier-Layrargues G. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study. AJR Am J Roentgenol 164: 997-1002, 1995.
26. Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig 70: 478-486, 1992.
27. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232-236, 1988.
28. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31: 864-871, 2000. (Pubitemid 30169932)
29. Marchesini G, Bianchi G, Lucidi P, Villanova N, Zoli M, De Feo P. Plasma ghrelin concentrations, food intake, and anorexia in liver failure. J Clin Endocrinol Metab 89: 2136-2141, 2004. (Pubitemid 38619842)
30. Merli M, Riggio O, Romiti A, Ariosto F, Mango L, Pinto G, Savioli M, Capocaccia L. Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology 12: 106-112, 1990.
31. Muller MJ, Bottcher J, Selberg O, Weselmann S, Boker KH, Schwarze M, von zur MA, Manns MP. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 69: 1194-1201, 1999. (Pubitemid 29252053)
32. Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 15: 782-794, 1992.
33. Nielsen MF, Caumo A, Aagaard NC, Chandramouli V, Schumann WC, Landau BR, Schmitz O, Vilstrup H. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiologic glucose and insulin concentrations. Am J Physiol Gastrointest Liver Physiol 288: G1135-G1143, 2005.
34. Orskov H, Thomsen HG, Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 219: 193-195, 1968.
35. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 19: 616-627, 1994. (Pubitemid 24066891)
36. Pirlich M, Schutz T, Spachos T, Ertl S, Weiss ML, Lochs H, Plauth M. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 32: 1208-1215, 2000.
37. Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Muller MJ. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 16: 43-55, 1997. (Pubitemid 27249892)
38. Plauth M, Schutz T, Buckendahl DP, Kreymann G, Pirlich M, Grungreiff S, Romaniuk P, Ertl S, Weiss ML, Lochs H. Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism. J Hepatol 40: 228-233, 2004.
39. Plauth M, Schutz T, Buckendahl DP, Kreymann G, Pirlich M, Grungreiff S, Romaniuk P, Ertl S, Weiss ML, Lochs H. Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism. J Hepatol 40: 228-233, 2004. (Pubitemid 38115826)
40. Raddatz D, Rossbach C, Buchwald A, Scholz KH, Ramadori G, Nolte W. Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS). Exp Clin Endocrinol Diabetes 113: 268-274, 2005.
41. Richardson RA, Davidson HI, Hinds A, Cowan S, Rae P, Garden OJ. Influence of the metabolic sequelae of liver cirrhosis on nutritional intake. Am J Clin Nutr 69: 331-337, 1999.
42. Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, Hamilton JA, Bengmark S, Williams R, Visvanathan K. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 37: 1154-1164, 2003.
43. Romiti A, Merli M, Martorano M, Parrilli G, Martino F, Riggio O, Truscelli A, Capocaccia L, Budillon G. Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital J Gastroenterol 22: 118-123, 1990.
44. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, Berger E, Blum U, Gabelmann A, Hauenstein K. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330: 165-171, 1994. (Pubitemid 24026884)
45. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, III, Shiffman ML, DeMeo J, Cole PE, Tisnado J. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 112: 889-898, 1997.
46. Schneeweiss B, Graninger W, Ferenci P, Eichinger S, Grimm G, Schneider B, Laggner AN, Lenz K, Kleinberger G. Energy metabolism in patients with acute and chronic liver disease. Hepatology 11: 387-393, 1990. (Pubitemid 20119992)
47. Selberg O, Burchert W, vd HJ, Meyer GJ, Hundeshagen H, Radoch E, Balks HJ, Muller MJ. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest 91: 1897-1902, 1993.
48. Shmueli E, Record CO, Alberti KG. Liver disease, carbohydrate metabolism and diabetes. Baillieres Clin Endocrinol Metab 6: 719-743, 1992.
49. Steele R, Wall JS, De Bodo RC, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
50. Stefankova J, Safka V, Fejfar T, Hulek P, Dresslerova I, Krajina A. [Effect of transjugular portosystemic shunt on insulin resistance]. Vnitr Lek 48: 1017-1024, 2002.
51. Surratt RS, Middleton WD, Darcy MD, Melson GL, Brink JA. Morphologic and hemodynamic findings at sonography before and after creation of a transjugular intrahepatic portosystemic shunt. AJR Am J Roentgenol 160: 627-630, 1993.
52. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103: 264-274, 1992.
53. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl 18: 118-125, 1966.